Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-02-26 @ 9:11 AM
Study NCT ID:
NCT03888534
Status:
WITHDRAWN
Last Update Posted:
2020-09-28
First Post:
2019-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization: